ENVERIC BIOSCIENCES INC (ENVB)
US29405E2081 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.86M | -17.29M | -18.47M | -48.98M | -6.86M | |||
| Depreciation Amortization | 338.98K | 343.98K | 330.00K | 650.00K | 120.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.10M | -174.75K | -220.00K | 1.19M | -370.00K | |||
| Interest Paid | 0.00 | 0.00 | 10.00K | 10.00K | N/A | |||
| Taxes Paid | 23.51K | 9.51K | N/A | N/A | N/A | |||
| Other non cash items | 2.45M | 3.03M | 1.21M | 35.68M | 3.22M | |||
| OPERATING CASH FLOW | -8.17M | -14.09M | -17.15M | -11.46M | -3.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -5.18K | -580.00K | -860.00K | N/A | |||
| Other Investing Activity | N/A | 16.85K | 0.00 | 3.06M | -40.00K | |||
| INVESTING CASH FLOW | N/A | 11.67K | -580.00K | 2.19M | -40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 1.67M | |||
| Stock Issued/Repurchased | 7.37M | -1.05M | 17.22M | 24.90M | 490.00K | |||
| Other Financing Activity | -342.54K | -291.08K | 960.00K | 0.00 | 3.37M | |||
| FINANCING CASH FLOW | 7.03M | -1.34M | 18.18M | 24.90M | 5.53M | |||
| Exchange Rate Effect | -12.11K | -10.02K | -80.00K | 140.00K | -60.00K | |||
| CHANGE IN CASH | -1.15M | -15.44M | 370.00K | 15.77M | 1.54M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.17M | -14.09M | -17.15M | -11.46M | -3.89M | |||
| Capital Expenditure | N/A | -5.18K | -580.00K | -860.00K | N/A | |||
| FREE CASH FLOW | -8.16M | -14.10M | -17.73M | -12.32M | -3.89M | |||
All data in USD